Vesicare (solifenacin)

Description

Vesicare contains solifenacin succinate, an antimuscarinic medicine. It reduces unwanted contractions of the bladder muscle and is licensed for the symptoms of overactive bladder: urgency, passing urine more often than usual, and urge incontinence. The tablet is swallowed whole with water once a day, with or without food.

Treatment usually begins at 5mg and may be increased to 10mg if the lower dose is not enough. Bladder training and advice on fluid and caffeine intake are used alongside the medicine. Dry mouth is the most common side effect; constipation, blurred vision, dry eyes, indigestion and urinary tract infection can also occur.

It is not suitable if you have urinary retention, uncontrolled narrow-angle glaucoma, myasthenia gravis, severe ulcerative colitis or toxic megacolon. Tell your prescriber if you have kidney or liver problems, a heart rhythm disorder, or take other medicines with antimuscarinic effects.

• Antimuscarinic tablets containing solifenacin succinate
• For urgency, frequency and urge incontinence of overactive bladder
• Tablets in 5mg and 10mg, taken once a day
• Swallow whole with water, with or without food
• Dry mouth and constipation are the most common side effects
• Not suitable with urinary retention or uncontrolled narrow-angle glaucoma